Cargando…
Serum laminin P1 in small cell lung cancer: a valuable indicator of distant metastasis?
Serum laminin P1 was studied in patients with small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), respiratory infections, pulmonary fibrosis, and in normal subjects. The level of serum laminin P1 was elevated (greater than 1.27 U ml-1) in 58.9% of SCLC and in 11.5% of NSCLC patients....
Autores principales: | Nakano, T., Iwahashi, N., Maeda, J., Hada, T., Higashino, K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977574/ https://www.ncbi.nlm.nih.gov/pubmed/1314070 |
Ejemplares similares
-
Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis
por: Lu, Hui, et al.
Publicado: (2021) -
Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma
por: Wang, Jin, et al.
Publicado: (2016) -
Prognostic effect of liver metastasis in lung cancer patients with distant metastasis
por: Ren, Yijiu, et al.
Publicado: (2016) -
Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
por: Gen, Soei, et al.
Publicado: (2022) -
Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis
por: Qi, Jing, et al.
Publicado: (2019)